Systematic analysis of host immunological pressure on the envelope gene of human immunodeficiency virus type 1 by an immunobioinformatics approach

被引:5
作者
Liang, Binhua
Luo, Ma
Ball, T. Blake
Yao, Xiaojian
Van Domselaar, Gary [1 ,2 ]
Cuff, Wilfred R. [2 ]
Cheang, Mary [4 ]
Jones, Steven J. M. [3 ]
Plummer, Francis A. [2 ]
机构
[1] Univ Manitoba, Fac Pharm, Winnipeg, MB R3T 2N2, Canada
[2] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada
[3] British Columbia Canc Res Ctr, Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada
[4] Univ Manitoba, Biostat Consulting Unit, Winnipeg, MB, Canada
基金
加拿大健康研究院;
关键词
human immunodeficiency virus type 1; envelope; host immune responses; positive selection; vaccine;
D O I
10.2174/157016208785132554
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
As the number of HIV-1 sequences has increased in the public database and new tools of immunological bioinformatics have become available, making it possible to better understand at a population level how host immune response drives the evolution of HIV-1 envelope (Env). We analyzed 1100 unique full-length envelope sequences and systematically determined positive selection (PS) sites by QUASI analysis and found that PS sites were widely dispersed across Env. The frequency of Env PS sites appears to be relatively stable over time. Moreover, between 25% and 61% of PS sites are shared between subtypes A, B, C, and D, suggesting that host immune responses target the same regions of Env gene across different clades at the population level. Significant correlations were observed between PS sites and Neutralizing antibody (NAb) response, as well as PS sites and Th epitopes. Furthermore, NAb sites in combination with cytotoxic-T lymphocyte (CTL) epitopes and proteasome cleavage sites were also significantly associated with PS sites, suggesting NAb may be the major force driving the evolution of HIV-1 Env. We also identified regions that are free from PS, but heavily targeted by CTL or NAb, implying that functional constraints may be responsible for the lack of positive selection in these regions. These findings should help researchers to identify epitopes or regions of HIV-1 that may aid in designing vaccines.
引用
收藏
页码:370 / 379
页数:10
相关论文
共 77 条
[1]  
Anisimova M, 2003, GENETICS, V164, P1229
[2]   Analysis of the interaction of antibodies with a conserved, enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120 [J].
Binley, JM ;
Wyatt, R ;
Desjardins, E ;
Kwong, PD ;
Hendrickson, W ;
Moore, JP ;
Sodroski, J .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (03) :191-198
[3]   CAUSES OF HIV DIVERSITY [J].
BONHOEFFER, S ;
HOLMES, EC ;
NOWAK, MA .
NATURE, 1995, 376 (6536) :125-125
[4]   HIV vaccine design and the neutralizing antibody problem [J].
Burton, DR ;
Desrosiers, RC ;
Doms, RW ;
Koff, WC ;
Kwong, PD ;
Moore, JP ;
Nabel, GJ ;
Sodroski, J ;
Wilson, IA ;
Wyatt, RT .
NATURE IMMUNOLOGY, 2004, 5 (03) :233-236
[5]   Positive selection detection in 40,000 human immunodeficiency virus (HIV) type 1 sequences automatically identifies drug resistance and positive fitness mutations in HIV protease and reverse transcriptase [J].
Chen, LM ;
Perlina, A ;
Lee, CJ .
JOURNAL OF VIROLOGY, 2004, 78 (07) :3722-3732
[6]   Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes [J].
Choisy, M ;
Woelk, CH ;
Guégan, JF ;
Robertson, DL .
JOURNAL OF VIROLOGY, 2004, 78 (04) :1962-1970
[7]  
da Silva J, 2003, CURR HIV RES, V1, P363
[8]   Molecular phylogenetic evidence of cytotoxic T lymphocyte (CTL) selection on human immunodeficiency virus type 1 (HIV-1) [J].
da Silva, J ;
Hughes, AL .
MOLECULAR BIOLOGY AND EVOLUTION, 1999, 16 (10) :1420-1422
[9]   Mapping sites of positive selection and amino acid diversification in the HIV genome: An alternative approach to vaccine design? [J].
de Oliveira, T ;
Salemi, M ;
Gordon, M ;
Vandamme, AM ;
van Rensburg, E ;
Engelbrecht, S ;
Coovadia, HM ;
Cassol, S .
GENETICS, 2004, 167 (03) :1047-1058
[10]   Prospects for an AIDS vaccine [J].
Desrosiers, RC .
NATURE MEDICINE, 2004, 10 (03) :221-223